3rd Epigenetics in Drug Discovery conference
3rd Epigenetics in Drug Discovery conference
|
Register
3 for the price of 2 with the coupon code
RCDVB! |
Download last year's Epigenetics
in Drug Design Brochure
 |
|
|
Dear Colleague,
GTC’s 3rd Epigenetics in Drug Discovery conference is the only epigenetics
conference that brings together a balanced mix of leading experts from the
industry and academia to collaborate on the latest cutting edge research on
novel epigenetic mechanisms, therapeutics, developments, biomarkers and
diagnostics. Venture Capitalists will also join the conference to discuss
investment opportunities and what they look for in the epigenetics space.
Some key discussions around epigenetics drug discovery at the conference
include: 1) The role of epigenetics in human diseases such as cancer, leukaemia,
neurodegenerative conditions, neuropsychiatric disorders, inflammation, etc. 2)
Novel mechanisms, biomarkers, technologies and diagnostics for epigenetics drug
discovery 3) Cutting edge research from GlaxoSmithKline, Epizyme, Genentech,
Constellation, Astex, Cellzome, RaNA Therapeutics, Pfizer, Harvard,
Massachusetts Institute of Technology, etc.
Conference sessions are:
Epigenetic Mechanisms
Role of Epigenetics in Human Diseases
Drug Discovery in Epigenetics
Preclinical and Clinical Development
Epigenetic Biomarkers and Diagnostics
Panel Discussion: Investment Opportunities in the Epigenetic Space
The conference will run parallel with the other exciting conferences:
7th Drug Design & Medicinal Chemistry
6th Imaging in Drug Discovery & Development
Orphan Drugs Research and Commercialization
Bring a team of 3 for the price of 2 by
registering with the coupon code rcdvb!
We look forward to seeing you at the conference!
|
| GOLD
SPONSOR |
|
 |
|
 |
|
|
MEDIA PARTNER |
|
 |
|
|
| |
 |
Attend ALL GTC Conferences for One Year
for only $3,995 ($1,990 for Acad/Govt).
Click
here to sign up! |
What Past Delegates Said About the Event:
“Fantastic opportunity to see the very latest research in epigenetics
drug-discovery.”
- Rab Prinjha, VP Head of Epinova DPU, GSK. |
|
|
